The “heart-on-a-chip” developed at UC Berkeley houses human heart tissue derived from adult stem cells. The system could one day replace animal models for drug safety screening. (Photo by Anurag Mathur, Healy Lab)
When UC Berkeley bioengineers say they are holding their hearts in the palms of their hands, they are not talking about emotional vulnerability
Instead, the research team led by bioengineering professor Kevin Healy is presenting a network of pulsating cardiac muscle cells housed in an inch-long silicone device that effectively models human heart tissue, and they have demonstrated the viability of this system as a drug-screening tool by testing it with cardiovascular medications.
This organ-on-a-chip, reported in a study published today (Monday, March 9) in the journal Scientific Reports, represents a major step forward in the development of accurate, faster methods of testing for drug toxicity. The project is funded through the Tissue Chip for Drug Screening Initiative, an interagency collaboration launched by the National Institutes of Health to develop 3-D human tissue chips that model the structure and function of human organs.
“Ultimately, these chips could replace the use of animals to screen drugs for safety and efficacy,” said Healy.
The study authors noted a high failure rate associated with the use of nonhuman animal models to predict human reactions to new drugs. Much of this is due to fundamental differences in biology between species, the researchers explained. For instance, the ion channels through which heart cells conduct electrical currents can vary in both number and type between humans and other animals.
“Many cardiovascular drugs target those channels, so these differences often result in inefficient and costly experiments that do not provide accurate answers about the toxicity of a drug in humans,” said Healy. “It takes about $5 billion on average to develop a drug, and 60 percent of that figure comes from upfront costs in the research and development phase. Using a well-designed model of a human organ could significantly cut the cost and time of bringing a new drug to market.”
Read more: Bioengineers put human hearts on a chip to aid drug screening
The Latest on: Organ-on-a-chip
via Google News
The Latest on: Organ-on-a-chip
- Heart-on-a-chip Measures in Vivo Cardiac Performanceon November 19, 2019 at 5:33 am
Stem cell-derived organ-on-a-chip technology can directly measure in vivo cardiac performance, reported by TARA Biosystems, Inc. from a study on investigational candidate MYK-491. The data will be ...
- TARA's organ-on-a-chip technology can directly measure in vivo cardiac performance, study showson November 18, 2019 at 2:01 pm
TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA's human iPSC-derived organ-on-a-chip technology can ...
- Heart-on-a-chip technology predicts preclinical systolic and diastolic in vivo observations for novel cardiac drug in developmenton November 18, 2019 at 1:15 pm
NEW YORK, November 18, 2019--TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA's human iPSC-derived ...
- Organ-on-a-Chip Market Various Business Strategies by Keyplayers Organovo, Hepregen, Hurel Corporation, Nortis, TissUse, Tara Biosystems, and AxoSimon November 11, 2019 at 9:20 am
Seattle, WA -- (SBWIRE) -- 11/11/2019 -- Organ-on-a-chip is expected to cater to wide range of applications ranging from disease modelling to patient stratification and phenotypic screening. Most of ...
- Organ-on-a-Chip: Global Markets - 4DCELL • AXOSIM • BEONCHIP • BIOIVT • BIOMIMX • CHERRY BIOTECH • CN BIO • ELVEFLOWon November 11, 2019 at 5:07 am
An organ-on-a-chip is a type of artificial organ that possesses the capability to simulate activities, mechanics and physiological response similar to that of an organ system. These are multi-channel ...
- Plant-based plastic chip used for medicine testingon November 8, 2019 at 4:28 pm
Organ-On-A-Chip is a new technology that uses plastic slides to simulate the workings of a human organ. Each chip is able to simulate how organs interact with drug treatments, cutting down on animal ...
- Explosion Of Interest In Organ-On-A-Chip Technologyon November 7, 2019 at 4:00 pm
November 25, 2019 | Organ-on-a-chip models were practically nonexistent a decade ago, but significant advances are now being made every few months. Among the many challenges facing researchers in the ...
- Will Organ-On-A-Chip Models Be Viable Alternatives to Animal Testing?on October 20, 2019 at 5:00 pm
November 20, 2019 | Organ-on-a-chip models could fundamentally change the way drugs make their journey to clinical trials and reduce the need for animals in laboratory experiments. The new testing ...
- Wake Forest regenerative medicine researchers gain $24M federal grant for body-on-a-chip studyon October 8, 2019 at 10:54 am
Federal health officials want to determine whether organ-on-a-chip technology can assist in understanding injuries and fatalities caused by inhaled chlorine gas — a potential national security threat ...
- Organ-on-a-Chip Market 2019 Global Analysis, Opportunities And Forecast To 2024on September 10, 2019 at 1:28 am
An organ-on-a-chip is a type of artificial organ that possesses the capability to simulate activities, mechanics and physiological response similar to that of an organ system. These are multi-channel ...
via Bing News
